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The pathogenesis of atherosclerosis, the major cause of cardiovascular diseases (CVD), is multifactorial and therefore
its treatment approaches and the ability to regress the plaque are complicated. Data from research on animal
models and clinical studies have indicated that moderate daily exercise can alleviate the risk for the development
of atherosclerotic plaques, while the same has not been true for the supplementation of antioxidants.
Study objectives: We proposed that mice supplemented with quercetin, a class of flavonoids known to have
antioxidant and anti-inflammatory properties, will have profound effects on the pathophysiology of atherosclerosis
when combined with exercise.
Study design: Forty C57BL6 LDLr −/− mice were divided into four groups (n = 10): control untreated (NN); control
group supplemented with 100 μg/day of quercetin (NQ); exercise group (EN); and exercise group supplemented with
100 μg/day of quercetin (EQ). All animals were fed atherogenic diet. The exercise groups were run on a treadmill for
30 minutes, 15 m/min for 5 days/week for 30 days. After 30 day animals were sacrificed and tissues were harvested.
Results and conclusion: Mice supplemented with quercetin during exercise sessions had 78% atherosclerotic plaque
reduction compared to control mice and 40% less atherosclerotic plaque formation compared to control group
supplemented with quercetin. The manifestation of the combination of quercetin supplementation with exercise was
more evident in the pro-reverse cholesterol transport genes, indicating a plausible mechanism for their combined
beneficial effect.
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Atherosclerosis is a chronic disease of the large arteries
and is a major cause of heart disease, stroke, and death in
westernized societies. The etiology of cardiovascular dis-
ease (CVD) is complex and multifactorial, however there is
substantial evidence [1,2] that oxidative stress [3] and in-
flammation [4] play an important role in the initiation and
progression of the disease. Oxidative modification of low
density lipoprotein (LDL) is believed to turn the otherwise
native lipoprotein into an antigenic molecule that attracts
monocytes turned macrophages to the vascular wall with a
subsequent triggering of a complex immune response me-
diated by inflammatory modulators [5-7]. Recent insights* Correspondence: Mahdi_Garelnabi@uml.edu
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unless otherwise stated.into the pathogenesis of atherosclerosis underscore the im-
portance of chronic inflammation in both the initiation
and progression of the disease [8-11].
Exercise which induces a severe oxidative stress result-
ing in the depletion of plasma and tissue antioxidants
has been shown to be an important deterrent of CVD
[12-14]. This paradigm is supported by a large number
of experimental animal studies and by epidemiological
investigations. Over the past 5 decades, numerous scien-
tific reports have examined the relationships between
physical activity, physical fitness, and cardiovascular health
[15-18]. Studies from our previous work have indicated
that exercise induced the reverse cholesterol transport in
mice that were exercised on a treadmill [19]. Others have
reported that mice fed a high fat diet had increased num-
bers of macrophage clusters in adipose tissue [20], which
were reduced by exercise training compared to sedentaryral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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necrosis factor α (TNF-α) mRNA, increased numbers of
CD11c inflammatory macrophages and CD8 T cells [20].
Recently published study by Wen et. al. [21] reported that
treadmill exercise training modulated hepatic cholesterol
metabolism and circulating PCSK9 concentration in high-
fat-fed mice.
Studies that combined antioxidants with exercise
have also shown conflicting outcomes. Early study by
Ramachandran et. al., [22] have showed that exercise
reduced preexisting atherosclerotic lesions in LDL re-
ceptor knockout (−/−) mice, and that the addition of
vitamin E supplementation to exercising did not reduce
atherosclerotic lesion formation significantly when com-
pared to untreated exercised mice [22]. Moreover, vitamin
E supplementation was found to counteract the beneficial
effects of exercise by preventing the induction of aortic
catalase activity and endothelial NO synthase expression
[23]. Flavonoids are a class of naturally occurring com-
pounds widely present in fruits, vegetables and beverages
derived from plants that have known antioxidant activity
[24,25]. One such flavonoid, quercetin, has been shown to
be an effective free-radical scavenger that inhibits lipo-
protein oxidation [24]. Recent studies have also suggested
that quercetin possesses anti-inflammatory properties as
well as antioxidant activity. As an antioxidant and anti-
inflammatory, quercetin appears to alleviate oxidative
stress via diverse pathways, including NF-κB dependent
mechanism [25], decrease activity of JAK3 [26], and/or
by blocking the activation of pro-inflammatory/oxidative
stress mediator signal transduction [27]. Quercetin has
also been shown to prevent the accumulation of fat
in the liver of mice fed a high fat diet [28] and to lo-
wer blood lipids in people with dyslipidemia [29]. Chang
et. al. [30] have demonstrated that quercetin promotes
cholesterol efflux from macrophages on a concentration-
dependent manner through ATP-binding cassette trans-
porter (ABCA-1) mediated mechanisms. It appears from
these studies that the combination of exercise and quer-
cetin supplementation may produce greater cardiovascular
benefits than exercise alone. We propose that quercetin
supplementation will have a profound effect on the patho-
physiology of atherosclerosis when combined with exer-
cise and that this action will be attributed to the inhibition
of lipid oxidation, lowering of arterial lipid deposition and
decreased development of plaque.
Materials and methods
Animals, diets, and exercise
All animal studies were performed in agreement with
Public Health Service policy on use of laboratory animals,
and in conformity with the Guide for the Care and Use of
Laboratory Animals published by the US National Insti-
tutes of Health. The animal use protocol was approved bythe Institutional Animal Care and Use Committee of
the University of Massachusetts Lowell. All animals
were fed an atherogenic diet containing 1.5% choles-
terol as part of a 42% Fat Kcal Diet without antioxidants
(Cat: TD.110489; Harlan Laboratories, Madison, WI).
Forty 4-week-old male LDLr−/−mice on C57BL/6 J
background (B6.129S7-Ldlrtm1Her/J strain) were obtained
from Jackson Laboratory (Bar Harbor, ME). Mice were
divided into four groups (10 mice each): control mice
(NN) left untreated; control mice supplemented with
quercetin (NQ); exercise group (EN); and exercise group
supplemented with quercetin (EQ). Animals groups sup-
plemented with quercetin were orally fed 100 μg/day,
5 days per week for 30 days 15 min prior to exercise.
The quercetin solution was prepared in water with 1%
sodium lauryl sulfate (SLS). Although the solution is
very stable however; was gently mixed before pipetting
to ensure correct dosage concentration. Pipette was used
to deliver the correct amount; mouse was held upright
until it swallowed the fluid. The exercise groups were
run on a treadmill (Columbus Instruments, Columbus,
OH) for 30 minutes at 15 meters/min, 5 days/week for
30 days.
Materials
Quercetin was purchased from Cayman Chemicals (Ann
Arbor, MI), with all other chemicals and reagents being
purchased from Sigma-Aldrich Chemical Co. (St. Louis,
MO). Gene expression reagents were obtained from Bio-
Rad (Hercules, CA). Primers were designed and purchased
along with TRIzol® from Life Technologies (Carlsbad, CA).
Methods
Initially animals were acclimatized to the housing facility
and the use of the treadmill instrument prior to starting
the actual protocol. After 30 days of treatment the ani-
mals were fasted overnight (>12 hours), sacrificed with
100% CO2 exposure, and blood was collected via cardiac
puncture. The plasma was collected after centrifugation
at 4°C at 3000 rpm for 20 min and frozen at −80°C until
assayed. The aorta and liver were perfused with cold
phosphate buffered saline (PBS) prior to being harvested.
All tissues were instantaneously frozen in liquid nitrogen
following collection and stored at −80°C until assayed.
Assessment of atherosclerotic lesions
At the completion of the livers perfusion and tissue col-
lection the aorta was kept wet with cold PBS through
the dissection process which was performed under a ste-
reomicroscope from the iliac bifurcation up to the heart,
including the beginning of the brachiocephalic, carotid,
and subclavian arteries. Pictures of the aorta were ob-
tained using a digital camera. Lesion area size was quan-
tified using Image J software [31]. The lesion area was
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vation and quantified.
Quantitative real-time PCR (qPCR)
Liver RNA was extracted using TRIzol according to the
manufacturer’s protocol and the quantity was measured
by Qubit (Life Technologies, Carlsbad, CA). cDNA was
generated from 10–100 ng of total RNA and 1/20th of
the sample was taken for qPCR. cDNA synthesis and
qPCRs were performed with SYBR GreenER Two-Step
qRT-PCR Kit according to the manufacturer’s protocol.
qPCR was run in 20 μL of reaction mixture in sealed 96-
well plates with iScriptTM Reverse Transcription Super-
mix and SsoFastTM EvaGreen® Supermix on an RTPCR
MyiQTM2 system (Bio-Rad; Hercules, CA). Threshold
cycle (CT) was determined by Bio-Rad iQ5 v.2.1 soft-
ware. The melting curve and efficiency were assessed for
all primer pairs. The level of mRNA was calculated usingFigure 1 Effect of quercetin and exercise on atherosclerotic lesion de
Atherosclerotic lesions in aortas of LDLr−/−mice fed a high-fat diet. NN: Co
treatment; EN: Mice on atherogenic diet and exercise without quercetin su
supplementation; EQ: Mice on atherogenic diet, exercise and quercetin suppl
control and relatively less lesion formation on the other groups. B: Lesions are
and exercise without quercetin intake NQ: Mice on atherogenic diet and que
intake. Compared to NN mice; the aorta lesion areas in EN, NQ and EQ showeglyceraldehyde 3-phosphate dehydrogenase (GAPDH) as
an internal control gene. Data are expressed as fold induc-
tion of mRNA level in one group compared to another.Enzyme-Linked Immunosorbent Assay (ELISA)
Plasma TNF-α, monocyte chemoattractant protein (MCP)-
1, and interleukin (IL)-17α levels were determined accord-
ing to manufacturer protocols by ELISA kits purchased
from BioLegend (San Diego, CA).Statistical analysis
All data are presented as mean ± SD. Statistical signifi-
cance for differences in lesion areas were evaluated using
Student’s t-test. Statistical significance for relative gene
expression was evaluated using one-way ANOVA with
Tukey post-hoc test using 95% confidence intervals. Dif-
ferences were considered significant at P <0.05.velopment. A: Images of the atherosclerotic lesions in aortas.
ntrol group; mice on atherogenic diet without quercetin and exercise
pplementation; NQ: Mice on atherogenic diet and quercetin
ementation. Massive formation of atherosclerotic plaque can be seen on
as dot plot representation in the 4 groups. EN: Mice on atherogenic diet
rcetin intake. EQ: Mice on atherogenic diet and exercise and quercetin
d significant decreases of 79%, 64% and 70% respectively (P < 0.05).
Figure 2 Effect of quercetin intake and exercise on selected
plasma biomarkers. Plasma levels of TNF-α, MCP-1 and IL-17α. The
figure shows average plasma levels of TNF-α (A), MCP-1 (B) and
IL-17 (C) . TNF-α levels significantly increased in the EN and NQ mice
compared to NN group. However no significant changes were noticed
between the groups MCP-1 and IL-17 levels.
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All mice completed the study, tolerated the supple-
mented quercetin amount; there was no differences in
the amount of consumed food between the groups or
the physical appearance of the mice as a result of the
quercetin intake. There was, however, a significant re-
duction in body weight in the EQ mice after 30 days of
treatment compared to baseline (data not shown). The
weight reduction appears to have resulted from the com-
bination of the exercise and quercetin intake; however
the mechanism for this weight loss is not very clear.
Atherosclerotic lesion
Atherosclerotic plaque formation in selected mice from
all groups is shown in Figure 1A. The average lesion areas
for the groups were: 56.04 mm2, 11.84 mm2, 19.95 mm2
and 16.63 mm2 for NN, EN, NQ, and EQ respectively, re-
vealing a decrease of 79% (P < 0.01); 64% (P < 0.05) and
70% (P < 0.05) between each group, respectively, and the
NN (Figure 1B).
Plasma cytokines
The plasma concentrations of IL-17, MCP-1 and TNF-α
measured by ELISA are shown in (Figure 2A,B and C).
The average plasma concentrations for TNF-α were:
473.1 pg/mL, 534.4 pg/mL, 534 pg/mL and 502.3 pg/mL
for the NN EN, NQ, and EQ groups respectively, de-
picting a significant increase (P < 0.05) in TNF-α level
among the EN and NQ groups compared to the NN
group.
On the other hand, plasma MCP-1 concentrations de-
creased among the EQ, EN, and NQ groups compared
to the NN. The greatest decrease was observed in the
EQ group (54.7%). The average plasma levels were:
2529.37 pg/mL, 2021.81 pg/mL, 1996.81 pg/mL, and
1384.69 pg/mL for the NN, EN, NQ, and EQ groups
respectively.
The average plasma concentrations of IL-17 were
8775.0 pg/mL, 8646.6 pg/mL, 8460.6 pg/mL, and
10,053.1 pg/mL for the NN EN, NQ, and EQ groups re-
spectively; showing an increase trend in the EQ group
compared to the NN group but not significantly.
Gene expressions in mouse liver
The mice in the EQ group showed a significant down
regulation of apolipoprotein (APO)A-1 gene expres-
sion levels compared to NN (Figure 3A). However, the
decrease in APOA-1 gene expression in the NQ and
EN groups was not significantly different from the NN
(Figure 3A). The APOA-1 gene expression level in the EQ
group was also significantly lower (P < 0.001) compared to
the EN group (Figure 3A). APOA-5 gene expression
showed similar trends with all treatment groups having
down regulated gene expression compared to the NNgroup. However, only the decrease in the EQ group was
significant (P < 0.001) compared to the NN (Figure 3B).
Interestingly, APOA-5 gene expression levels were signifi-
cantly higher in the EQ compared to the NQ group as
well (Figure 3B). Ironically, gene expressions for APOA-4,
ABCA-1, and peroxisome proliferator-activated receptor
(PPAR)-α followed a contrasting trend to what was ob-
served with the APOA-1 and APOA-5. ABCA-1 gene
expression was significantly (P < 0.001) up regulated in the
EQ group compared to NN group (Figure 3B). Fur-
thermore, the EQ group showed a significant (P < 0.05)
ABCA-1 gene induction compared to the NQ group
Figure 3 Selected lipoproteins associated mRNA gene expression levels. Levels of APOA-1, APOC3, APOA-4 mRNA expressions (A) and
APOA-5, ABCA-1 and PPAR-α mRNA expression (B) are shown in these figures.
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lated among all treatment groups compared to the NN
group, however, only the difference between the EN and
NQ groups was significant (P < 0.05) (Figure 3A). PPAR-α
gene expression levels were also increased in all treatment
groups compared to the NN group (Figure 3B). The EQ
was shown to have the most significant induction (P <
0.001) compared to the NN group (Figure 3B). APOC-3
gene expression was up regulated with exercise, with the
differences between NE group and NN group being sig-
nificant (P < 0.05) (Figure 3A). A similar trend was ob-
served between the EQ group and NQ group but not
significantly (Figure 3A), which may suggest that quer-
cetin and exercise down regulate APOC-3.
The liver gene expression for the inflammatory, oxida-
tive stress markers and transcription factors; signal trans-
ducer and activator of transcript (STAT)3, paraoxonase/
arylesterase (PON)1, nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB), and suppressor
of cytokine signaling (SOCS)1 showed varied responses.While exercise appears to down regulate STAT3 gene ex-
pression; it up regulated PON1 gene expression with no
effect for the quercetin supplementation compared to the
NN group (Figure 4A). SOCS1 was influenced by the exer-
cise depicting up regulation in the exercise groups com-
pared to the NN group but none of these changes was
significant (Figure 4B). NF-κB gene expression levels var-
ied, however, the EQ group had a significant (P < 0.05) in-
duction compared to the EN group (Figure 4B).
Discussion
Considerable attention has been given to polyphenols,
such as quercetin, due to their anti-inflammatory and
antioxidant properties [27-30]. Several mechanisms have
been described and attributed to the anti-atherogenic ef-
fects of exercise and quercetin. It is commonly accepted
that moderate exercise is an important component of a
healthy lifestyle that helps to prevent or delay the onset
of coronary artery disease [15-18]. These beneficial ef-
fects are lost when subjects become sedentary. Exercise
Figure 4 Selected inflammation and oxidative stress associated
gene expression levels. Average relative level of mRNA expression
for STAT3, and PON1 (A). (The differences between the levels of
PON1 and STAT3 in the various groups were not significant). (B)
Average of relative level of mRNA of NF-κB and SOCS1expression
(no significant differences between the groups), up regulation of
NF-κB among the EQ is significant.
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the cardiovascular beneficial effects [32,33]. A wide range
of mechanisms have been described for the beneficial
effects of exercise; including: enhancing serum HDL
levels; up regulation of PON1 and SRB1; inducing anti-
inflammatory cytokines; and up regulation of the antio-
xidant enzymes contributing towards their ability to
counteract the oxidative stress that is generated dur-
ing exercise [34-36]. Quercetin on the other hand has
been shown to act through various mechanisms mainly
linked to reducing the inflammation and oxidative stress
levels which are responsible for the atherosclerotic pa-
thogenesis. Earlier studies have shown that quercetin
significantly inhibit in vitro LDL oxidation, and also pro-
tects macrophages from oxidized low-density lipoprotein-
induced apoptosis [37,38]. Quercetin has also been
reported to inhibit the progression of atherosclerosis
via up-regulating the expression of PON1 [18]; indicating
a possible cholesterol reverse transportation mechanism.
Studies combining antioxidants with exercise are not
new; our previous work has extensively studied thepossible role of the intake of antioxidant vitamins, such as
vitamin E during exercise on cardiovascular health in
humans and mouse models. However, the current study is
unique in a way, it has combined quercetin supplementa-
tion with exercise to examine their anti-atherogenic roles.
To our knowledge this has not been explored previously.
The C57BL LDLr−/− mouse model has been commonly
used for the rapid development of the atherogenic diet-
induced atherosclerotic plaque. One of the major findings
in the current study is the atherosclerotic reduction in the
three groups of mice on exercise alone, exercise with
quercetin supplementation, and quercetin supplementa-
tion alone. The current quercetin dosage was selected
since mice have been previously shown to tolerate and re-
spond to this concentration (28). Exercise is well known
to help reduce plaque formation [22]; however, earlier
work by Parthasarathy’s group did not find significant re-
duction in the aortic plaque formation in exercising LDL
receptor-deficient mice supplemented with vitamin E [23].
Moreover, it appears that vitamin E offset the beneficial ef-
fects of exercise by preventing the induction of aortic cata-
lase activity and endothelial NO synthase expression [23].
The duration of this study was 30 days, which was suffi-
cient to allow fatty streaks and plaque development to re-
semble early atherosclerosis development. We also chosen
low intensity exercise regimen to provide the opportunity
to study the effect of the combination of quercetin with
low intensity exercise on the plaque formation. In the
current study, we observed a 64-79% reduction in plaque
formation in all treatment groups compared to control.
Exercise alone greatly reduced plaque formation. Con-
versely quercetin supplementation alone and with exercise
resulted in similar reductions of plaque formation. This
outcome suggests a strong anti-athrogenic role for quer-
cetin supplementation.
To further investigate the mechanisms that may have
contributed to the reduced plaque formation, we mea-
sured plasma lipids, selected cytokines, and we assessed
certain genes expression in mouse livers. Interestingly
there were no significant changes in the plasma lipids
profiles (data not shown). There was a slight increase in
the plasma TNF-α levels in the treated groups compared
to control, however, the changes between the group on
the quercetin supplementation alone and the control
was the only difference in TNF-α that was significant. It
is not clear why this difference was observed considering
the known anti-inflammatory role for quercetin. Plasma
MCP-1 levels on the other hand slightly decreased with
exercise or quercetin supplementation alone greatly de-
creased with the combination of the exercise and quer-
cetin supplementation. MCP-1 is critical for the initiation
and development of atherosclerotic lesions. It is known to
participate in the progression of atherosclerosis, by pro-
moting direct migration of inflammatory cells to the
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sclerotic lesions using specific antibodies [35]. It appears
quercetin supplementation alone or combined with exer-
cise has potent anti-MCP-1 effects. Plasma IL-17α levels
decreased with exercise or quercetin supplementation
alone and slightly increased with the combination of
the two. IL-17α plays an important pro-inflammatory
role in atherosclerotic plaque development. Interestingly
plasma IL-17α levels were decreased with exercise or
quercetin intake but not with the combination. Interleukin
17 acts as a potent mediator by increasing chemokine pro-
duction in various tissues to recruit monocytes and neu-
trophils to the site of inflammation, its involvement in
inducing and mediating pro-inflammatory responses is
well understood. It is not clear if the combination of exer-
cise and quercetin will mediate IL 17 levels as indicated by
this result.
The gene expression data shown in this study for
lipoprotein is differentiated. The discrepancy between
the treatment and the control groups for the APOA-1,
APOC-3, and APOA-5 genes cannot be explained. How-
ever, on other lipoprotein metabolism associated genes,
specifically, ABCA-1, PPAR-α, and APOA-4 did show
significant up regulation among the treatment groups
compared to the control, indicating that quercetin sup-
plementation alone or with exercise may modulate the
reverse cholesterol transport genes. Recent reports have
shown that quercetin does modulate lipid reduction. Earl-
ier studies by us and others [19] have shown that exercise
promotes plasma lipid reductions. PON1 gene expression
was up regulated among exercise groups compared to the
control. This data goes along the ABCA-1 data suggesting
a reverse transportation mechanism which may be res-
ponsible for the decreased plaque formation. The changes
in NF-κB regulations among all treatment groups com-
pared to the control indicate a possible reduced plaque
formation mechanism mediated by NF-κB. Previous stud-
ies have pointed to NF-κB as potentially one of the most
important pro-inflammatory pathways in atherosclerosis
[36]. NF-κB is known to be activated in smooth muscle
cells, macrophages, and endothelial cells in atherosclerotic
lesions. In this study its gene induction levels appears to
be at the intersection of the acute inflammatory response
accompanying the acute atherosclerotic plaque formation.
SOCS1 and STAT3 demonstrated varied responses to ex-
ercise and quercetin supplementation between the various
groups. While STAT3 gene expression levels appear down
regulated in the treatment groups compared to the con-
trol, SOCS1 was up regulated in these groups compared
to the control, although none of these changes were
significant. SOCS-1 is known to potently restrict transduc-
tion of various inflammatory signals and, thereby mo-
dulate T-cell development. STAT3 activation by selected
cytokines such IL-6 is known to preferentially induce pro-inflammatory responses, whereas other sets of cytokines
such as IL-10 may activate STAT3 and promote an anti-
inflammatory response. In the current study, quercetin
supplementation and exercise, which are known for sti-
mulating anti-inflammatory responses, may have activated
STAT3 by a specific mechanism which resulted in de-
creased plaque formation [39].
In conclusion, we demonstrated that intake of quer-
cetin alone or along with exercise will result in reduced
atherosclerotic plaque formation. We speculate that these
changes may have resulted from modulation of lipid
metabolism, possibly by stimulating cholesterol reverse
transport lipoprotein genes and through a set of anti-
inflammatory cytokine genes. The manifestation of the
combination of quercetin supplementation with exercise
was more evident in the pro-reverse cholesterol transport
genes indicating a plausible mechanism for their beneficial
effect.
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